Hermetica Superfood Encyclopedia
The Short Answer
Mora (Gloriosa superba) contains colchicine, an alkaloid that binds beta-tubulin and inhibits microtubule polymerization, simultaneously blocking neutrophil chemotaxis and NLRP3 inflammasome activation to produce anti-inflammatory and antimitotic effects. In vitro, methanolic seed extracts demonstrated an IC₅₀ of 19.52 µg/mL against MDA-MB-231 breast cancer cells, outperforming doxorubicin in cell-based assays, though no confirmatory human clinical trials have been conducted.
CategoryHerb
GroupAfrican
Evidence LevelPreliminary
Primary KeywordGloriosa superba benefits
Mora — botanical close-up
Health Benefits
**Anti-inflammatory and Antigout Activity**
Colchicine inhibits NLRP3 inflammasome activation and neutrophil chemotaxis, reducing urate crystal-mediated inflammation; pharmaceutical colchicine derived from related species is a first-line gout treatment at 0.5–1.2 mg/day.
**Antipyretic Effects**
Traditional Ayurvedic and African preparations use tuber decoctions to reduce fever; bioactive saponins and salicylic acid identified via GC-MS in tuber extracts are hypothesized to contribute to heat-lowering activity alongside colchicine's anti-inflammatory cascade.
**Antimicrobial and Antiparasitic Action**
Tuber extracts have demonstrated antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA) with inhibition zones of 20 mm in disc diffusion assays; saponins and tannins are implicated in membrane disruption against both bacteria and ectoparasites such as head lice.
**Anticancer Potential**: Methanolic seed extracts exhibited IC₅₀ values of 19
52 µg/mL against MDA-MB-231 breast cancer cells in MTT assays, achieving 60–80% inhibition at 50 µg/mL; colchicine's antimitotic mechanism arrests tumor cells in metaphase by preventing spindle fiber formation.
**Anthelmintic and Antiparasitic Use**
Traditional formulations in Ayurveda and Siddha employ powdered tubers for worm infestations; alkaloids including gloriosine and colchicoside are proposed to disrupt neuromuscular function in helminths, though mechanistic human data are absent.
**Enzyme Inhibition Activity**
Tuber extracts have shown 90% lipoxygenase inhibition and 83.50% acetylcholinesterase inhibition in preclinical bioassays, suggesting potential roles in managing oxidative inflammatory cascades and neurological conditions, respectively.
**Cytogenetic and Agricultural Utility**
Colchicine extracted from Gloriosa superba is used globally to induce polyploidy in plant breeding by blocking cell division at metaphase, representing one of the most commercially validated applications of the plant's primary bioactive compound.
Origin & History
Natural habitat
Gloriosa superba is native to tropical Africa and Asia, thriving in sandy, well-drained soils across sub-Saharan Africa, India, Sri Lanka, and Southeast Asia at elevations up to 2,500 meters. The plant is a climbing lily that grows from underground corm-like tubers and is cultivated commercially in India—particularly in West Bengal, Sikkim, Orissa, and Tamil Nadu—primarily for colchicine extraction. India is the world's leading producer, with distinct regional chemotypes exhibiting significantly different alkaloid concentrations depending on soil, altitude, and genetic lineage.
“Gloriosa superba has been documented in Ayurvedic, Siddha, and Unani medical systems for centuries, where it is referred to as 'Langli' or 'Kalihari' and prescribed for gout, rheumatism, abdominal colic, difficult labor, skin diseases, and anthelmintic purposes, with the tuber being the primary medicinal part. In African traditional medicine, particularly across East and Central Africa, the plant—locally called mora and other vernacular names—is used topically and orally for treating gonorrhea, reducing fever, and killing head lice, reflecting a parallel ethnopharmacological tradition independent of South Asian usage. Colonial-era botanical records from the 18th and 19th centuries document its abortifacient use, which corresponds to colchicine's documented teratogenicity and uterotonic properties. Demand for the plant escalated significantly in the 20th century when G. superba was identified as an accessible source of colchicine for both pharmaceutical production and agricultural polyploidy research, leading to large-scale commercial cultivation programs in Tamil Nadu, India.”Traditional Medicine
Scientific Research
The evidence base for Gloriosa superba as a whole-plant extract is limited to in vitro cell studies and animal models; no published randomized controlled trials in humans have evaluated G. superba extracts for any of its traditional indications. Anticancer activity has been demonstrated in MTT-based cytotoxicity assays (IC₅₀ 19.52 µg/mL against MDA-MB-231 cells), and antibacterial activity was measured via disc diffusion (20 mm inhibition zones against MRSA), but these findings have not been replicated in animal models or translated to human trials. The clinical evidence for colchicine's anti-inflammatory effects in gout and pericarditis derives from pharmaceutical-grade colchicine sourced from Colchicum autumnale and is not directly transferable to G. superba extracts, which have highly variable alkaloid concentrations across chemotypes (2.12–7.58 mg/g tuber dry weight). Overall, the evidence score for G. superba as a botanical supplement is low, and robust human efficacy and safety data are absent, limiting its therapeutic utility outside of traditional contexts.
Preparation & Dosage
Traditional preparation
**Traditional Tuber Decoction**
Tubers are cleaned, thinly sliced, sun-dried, and powdered; small quantities (doses unspecified in safe human ranges) are boiled into decoctions for topical or oral use in Ayurvedic and African traditions.
**Topical Paste**
Crushed fresh tuber paste is applied externally for skin conditions, wounds, and head lice infestations; no standardized application amount has been clinically established.
**Research Extracts (In Vitro Only)**
30–60 mg/mL; these concentrations are not translatable to human supplemental doses
Methanolic and aqueous extracts tested in laboratory settings at concentrations of .
**Pharmaceutical Colchicine Reference Dose**
2 mg/day for gout prophylaxis under medical supervision; this should not be used to infer a safe extract dose
Purified colchicine (not G. superba extract) is administered at 0.5–1..
**Standardization**
58 mg/g in tubers and 6–9 mg/g in seeds across chemotypes
No commercial supplements are standardized to colchicine content from G. superba; alkaloid content varies from 1.5–7..
**CAUTION**
No safe self-supplementation dose exists for raw Gloriosa superba material; its use without pharmaceutical supervision is strongly discouraged due to narrow therapeutic index.
Nutritional Profile
Gloriosa superba is not consumed as a food crop and does not contribute meaningfully to macronutrient or micronutrient dietary intake due to its toxicity. The primary phytochemical content includes colchicine (1.5–3 mg/g in tubers; 6–9 mg/g in seeds), gloriosine, colchicoside, and superbine as principal alkaloids. Secondary metabolites identified by GC-MS and TLC include flavonoids (contributing antioxidant capacity), saponins, tannins, sterols, salicylic acid, benzoic acid, and various fatty acids, with seeds yielding 17 identified compounds versus 9 in tubers. Bioavailability of colchicine from plant extracts is expected to be variable and unpredictable due to matrix effects, processing method, chemotype differences, and the presence of competing alkaloids; pharmaceutical colchicine is well absorbed orally with a bioavailability of approximately 45% and a Tmax of 0.5–2 hours.
How It Works
Mechanism of Action
Colchicine, the principal alkaloid in Gloriosa superba, binds with high affinity to the beta-tubulin subunit of tubulin dimers at the colchicine-binding site, preventing polymerization into microtubules and thereby arresting mitosis at metaphase—an antimitotic effect exploited both in cytogenetics and as a basis for anticancer research. In the inflammatory context, colchicine disrupts microtubule-dependent neutrophil migration, degranulation, and superoxide production, and additionally inhibits the NLRP3 inflammasome assembly, reducing caspase-1 activation and downstream interleukin-1β and interleukin-18 secretion. Secondary bioactives including flavonoids contribute to antioxidant activity by scavenging reactive oxygen species, while saponins and tannins disrupt microbial and parasitic cell membranes through surfactant-like interactions. Salicylic acid and benzoic acid detected by GC-MS in tuber extracts may provide supplementary cyclooxygenase inhibition, contributing to the antipyretic and analgesic effects reported in traditional medicine.
Clinical Evidence
No human clinical trials investigating Gloriosa superba extracts as a botanical intervention have been identified in the available literature. Preclinical in vitro findings include cytotoxic activity against breast cancer cell lines (IC₅₀ 19.52 µg/mL, MTT assay) and antibacterial efficacy against MRSA (20 mm inhibition zones), but these cannot be extrapolated to human dosing or outcomes without further bridging studies. Colchicine's clinical profile in humans—established through multiple RCTs for gout and cardiovascular inflammation—is relevant but pertains to purified pharmaceutical-grade colchicine, not raw plant extracts, which carry unpredictable alkaloid loads. Confidence in G. superba's clinical benefits for gonorrhea, head lice, or antipyresis remains very low, resting primarily on ethnobotanical reports and mechanistic plausibility rather than controlled evidence.
Safety & Interactions
Gloriosa superba carries a high toxicity profile due to colchicine's extremely narrow therapeutic index; ingestion of tubers or seeds can cause severe gastrointestinal distress (nausea, vomiting, profuse diarrhea), followed by multi-organ failure, bone marrow suppression, peripheral neuropathy, alopecia, and death—even small amounts (a few grams of tuber or seeds) have caused fatal poisoning in documented case reports. Critical drug interactions include CYP3A4 inhibitors (e.g., clarithromycin, ketoconazole, grapefruit) and P-glycoprotein inhibitors (e.g., cyclosporine, verapamil), which dramatically elevate colchicine plasma concentrations and precipitate toxicity; concurrent use with statins increases the risk of myopathy and rhabdomyolysis. Absolute contraindications include pregnancy (documented abortifacient and teratogenic effects), lactation, pediatric use, and patients with renal or hepatic impairment, as colchicine clearance is reduced in these populations. No safe upper limit for G. superba extract consumption has been established, and the plant is classified as a Schedule E1 poison in India; unsupervised ingestion or topical misuse is strongly discouraged.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Gloriosa superbaGlory LilyFlame LilyKalihariLangliMalabar Glory LilyClimbing Lily
Frequently Asked Questions
What is mora (Gloriosa superba) used for in traditional medicine?
In African traditional medicine, mora is used to treat gonorrhea, head lice, and fever, typically applied as topical tuber pastes or oral decoctions. In Ayurvedic and Siddha systems, it is prescribed for gout, rheumatism, abdominal colic, and as an anthelmintic, with the tuber being the primary medicinal part prepared by drying and powdering.
Is Gloriosa superba safe to consume or supplement with?
Gloriosa superba is considered highly toxic and is not safe for unsupervised self-supplementation; its tubers and seeds contain colchicine at concentrations of 1.5–7.58 mg/g and 6–9 mg/g respectively, which can cause fatal multi-organ failure. It is classified as a Schedule E1 poison in India, and ingestion of even small amounts of raw plant material has caused documented deaths.
What is the active compound in Gloriosa superba and how does it work?
The primary active compound is colchicine, an alkaloid that binds to the beta-tubulin subunit of tubulin dimers, preventing microtubule polymerization and arresting cell division at metaphase. It also inhibits the NLRP3 inflammasome and blocks neutrophil chemotaxis, explaining its anti-inflammatory effects in conditions like gout and acute pericarditis.
Does Gloriosa superba have any proven anticancer effects?
In vitro studies have shown that methanolic seed extracts of G. superba exhibit an IC₅₀ of 19.52 µg/mL against MDA-MB-231 human breast cancer cells, outperforming doxorubicin in cell-based assays. However, these are preliminary laboratory findings with no confirmatory animal or human clinical trial data, so anticancer efficacy in humans remains unproven.
How does Gloriosa superba interact with medications?
Colchicine from Gloriosa superba is metabolized by CYP3A4 and transported by P-glycoprotein, meaning inhibitors of these pathways—such as clarithromycin, ketoconazole, cyclosporine, or verapamil—can dramatically increase colchicine plasma levels and precipitate life-threatening toxicity. Concurrent use with statins also heightens the risk of myopathy and rhabdomyolysis, making G. superba preparations particularly dangerous in patients on multiple medications.
What is the difference between mora (Gloriosa superba) and pharmaceutical colchicine for gout treatment?
Pharmaceutical colchicine is a purified, standardized compound extracted from Gloriosa superba and related species, with a precise dosage of 0.5–1.2 mg/day proven effective for acute gout attacks. Mora herb preparations contain colchicine in variable concentrations and are not FDA-approved or standardized for gout treatment, making dosing unpredictable and clinical efficacy difficult to verify. The pharmaceutical form has established pharmacokinetics, contraindications, and drug interaction profiles, whereas herbal mora lacks this clinical validation.
Who should avoid mora (Gloriosa superba) supplementation?
Pregnant and nursing women should strictly avoid mora due to colchicine's teratogenic and embryotoxic properties documented in animal studies. Individuals with kidney or liver disease should avoid it, as colchicine is hepatically metabolized and renally eliminated, increasing toxicity risk. People taking P-glycoprotein inhibitors, CYP3A4 inhibitors, or other gout medications should consult a healthcare provider before use due to significant drug interaction potential.
How does the anti-inflammatory mechanism of mora (Gloriosa superba) differ from conventional anti-inflammatory supplements?
Mora's colchicine works by inhibiting NLRP3 inflammasome activation and blocking neutrophil chemotaxis, a mechanism distinct from NSAIDs (which inhibit cyclooxygenase) or curcumin (which targets NF-κB pathways). This specific action makes it particularly effective for crystal-mediated inflammation like gout, rather than general inflammatory conditions. The NLRP3-targeting mechanism explains why mora has narrow therapeutic application compared to broader-spectrum anti-inflammatory herbs.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w mora-gloriosa-superba curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
